Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01182805 · ClinicalTrials.gov registry record · Phase 1
Radiofrequency-based Speckle Tracking Echocardiography to Evaluate Diastolic Function
A Phase 1 study, sponsored by University of Michigan.
- Completed
- Registry status
- Phase 1
- Development phase
- 50
- Enrollment target
NCT01182805 is a Phase 1 study that has completed, run by University of Michigan. The registered enrollment target is 50 participants.
The verdict
NCT01182805, a Phase 1 study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate a novel ultrasound system's ability to assess the relaxing properties of the heart compared to current techniques.
Interventions
- DEVICE Echocardiography system Ultra DCI Model 5000
- DEVICE Echocardiography machine GE Vivid E9
- DEVICE Diastolic function assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2010-08 |
| Est. Completion | 2010-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01182805
The ClinicalTrials.gov registry entry for NCT01182805 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Echocardiography system Ultra DCI Model 5000 is the first listed.
NCT01182805 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01182805 about?
NCT01182805 is a clinical study titled "Radiofrequency-based Speckle Tracking Echocardiography to Evaluate Diastolic Function". The purpose of this study is to evaluate a novel ultrasound system's ability to assess the relaxing properties of the heart compared to current techniques.
What is the current status of trial NCT01182805?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 50 participants. The study started on 2010-08. Estimated completion is 2010-12.
What interventions are being tested in trial NCT01182805?
The interventions under investigation include: Echocardiography system Ultra DCI Model 5000 (DEVICE), Echocardiography machine GE Vivid E9 (DEVICE), Diastolic function assessment (DEVICE).
Who is sponsoring clinical trial NCT01182805?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.